These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 11139965

  • 1. Can the assessment of dynamic QT dispersion on exercise electrocardiogram predict sudden cardiac death in hypertrophic cardiomyopathy?
    Yi G, Poloniecki J, Dickie S, Elliott PM, Malik M, McKenna WJ.
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1953-6. PubMed ID: 11139965
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Usefulness of surface electrocardiogram in predicting the clinical course of patients with hypertrophic cardiomyopathy.
    Bayrak F, Kahveci G, Mutlu B, Değertekin M, Demirtaş E.
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():178-81. PubMed ID: 17584718
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Orosz A, Baczkó I, Nagy V, Gavallér H, Csanády M, Forster T, Papp JG, Varró A, Lengyel C, Sepp R.
    Can J Physiol Pharmacol; 2015 Sep; 93(9):765-72. PubMed ID: 26313025
    [Abstract] [Full Text] [Related]

  • 8. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C, Barletta G, Badia T, Capalbio A, Del Bene R, Franchi F, Gensini GF, Michelucci A.
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [Abstract] [Full Text] [Related]

  • 9. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone.
    Fei L, Slade AK, Grace AA, Malik M, Camm AJ, McKenna WJ.
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2222-7. PubMed ID: 7845847
    [Abstract] [Full Text] [Related]

  • 10. QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal.
    Magrì D, Santolamazza C, Limite L, Mastromarino V, Casenghi M, Orlando P, Pagannone E, Musumeci MB, Maruotti A, Ricotta A, Oliviero G, Piccirillo G, Volpe M, Autore C.
    J Cardiol; 2017 Oct; 70(4):310-315. PubMed ID: 28341542
    [Abstract] [Full Text] [Related]

  • 11. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features.
    Counihan PJ, Fei L, Bashir Y, Farrell TG, Haywood GA, McKenna WJ.
    Circulation; 1993 Oct; 88(4 Pt 1):1682-90. PubMed ID: 8403313
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the QT indices and the microvolt-level T wave alternans in cardiomyopathy.
    Kuroda N, Ohnishi Y, Adachi K, Yokoyama M.
    Jpn Circ J; 2001 Nov; 65(11):974-8. PubMed ID: 11716250
    [Abstract] [Full Text] [Related]

  • 13. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Fei L, Goldman JH, Prasad K, Keeling PJ, Reardon K, Camm AJ, McKenna WJ.
    Eur Heart J; 1996 Feb; 17(2):258-63. PubMed ID: 8732380
    [Abstract] [Full Text] [Related]

  • 14. Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.
    Mohiddin SA, Begley D, Shih J, Fananapazir L.
    J Am Coll Cardiol; 2000 Dec; 36(7):2270-8. PubMed ID: 11127472
    [Abstract] [Full Text] [Related]

  • 15. Ventricular Repolarization Dispersion is a Potential Risk for the Development of Life-Threatening Arrhythmia in Children with Hypertrophic Cardiomyopathy.
    Tashiro N, Muneuchi J, Ezaki H, Kobayashi M, Yamada H, Sugitani Y, Watanabe M.
    Pediatr Cardiol; 2022 Oct; 43(7):1455-1461. PubMed ID: 35284943
    [Abstract] [Full Text] [Related]

  • 16. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

  • 17. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
    Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K, Itoh H, Iwaki T, Oe K, Konno T, Mabuchi H.
    Clin Cardiol; 2002 Jul; 25(7):335-9. PubMed ID: 12109867
    [Abstract] [Full Text] [Related]

  • 18. Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy.
    Uchiyama K, Hayashi K, Fujino N, Konno T, Sakamoto Y, Sakata K, Kawashiri MA, Ino H, Yamagishi M.
    Ann Noninvasive Electrocardiol; 2009 Jan; 14(1):65-71. PubMed ID: 19149795
    [Abstract] [Full Text] [Related]

  • 19. Can QT/RR relationship differentiate between low- and high-risk patients with hypertrophic cardiomyopathy?
    Quinteiro RA, Biagetti MO, Fernandez A, Borzone FR, Gargano A, Casabe HJ.
    Ann Noninvasive Electrocardiol; 2015 Jul; 20(4):386-93. PubMed ID: 25639818
    [Abstract] [Full Text] [Related]

  • 20. T wave complexity in patients with hypertrophic cardiomyopathy.
    Yi G, Prasad K, Elliott P, Sharma S, Guo X, McKenna WJ, Malik M.
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2382-6. PubMed ID: 9825352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.